T. Rowe Price Associates »

Applied Therapeutics shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Applied Therapeutics (APLT) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Applied Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Applied Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Applied Therapeutics by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2024-09-30 $8.7M 1.0M 8.50
2024-06-30 $0 31k 0.00
2021-03-31 $208k 11k 18.76
2020-12-31 $241k 11k 21.99
2020-03-31 $1.1M 33k 32.68

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Apple Comm Stk (AAPL)
Nvidia Corporation Comm Stk (NVDA)
Amazon Comm Stk (AMZN)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Alphabet Comm Stk (GOOGL)
Unitedhealth Group Comm Stk (UNH)
Alphabet Comm Stk (GOOG)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Netflix Comm Stk (NFLX)
Tesla Comm Stk (TSLA)
Intuitive Surgical Comm Stk (ISRG)
Thermo Fisher Scientific Comm Stk (TMO)

View all positions for T. Rowe Price Associates

Top funds holding Applied Therapeutics

VR Adviser
Perceptive Advisors
Henderson Group
BlackRock
Franklin Resources
BlackRock
Propel Bio Management
Knoll Capital Management
Vanguard Group
Deutsche Bank Aktiengesellschaft
Morgan Stanley
Simplify Asset Management
Tang Capital Management
Geode Capital Management
Stempoint Capital

View all funds holding Applied Therapeutics